Roche NimbleGen last week launched its Gene Expression 12x135K Microarray format, a new multiplex gene expression array on its HD2 platform.
The 12-plex format enables users to analyze 12 independent samples simultaneously on a single slide, the company said. With 135,000 long oligonucleotide probes per array, complete transcriptome coverage can also be achieved.
NimbleGen is offering eight eukaryotic catalog designs in the new format – human, mouse, rat, A. thaliana, C. elegans, D. melanogaster, S. cerevisiae, and S. pombe. The company said it also offers custom-designed arrays in the new format.
Signature Genomic Laboratories last week announced that it has waived the 25 percent deposit previously required of patients for insurance billing.
Rather than pay a deposit prior to the initiation of testing, patients with private insurance can now request an insurance benefits investigation prior to or concurrent with sample processing through Signature's Patient Advocacy Program. Signature's patient advocacy team will communicate with the patient's insurance carrier on the patient's behalf to determine coverage.
Signature offers array-based cytogenetics testing for mental retardation and birth defects through its lab in Spokane, Wash.